Browsing Tag
regulatory affairs
2 posts
Curi Bio and Battelle partner to scale human-relevant neuromuscular testing platforms as FDA shifts toward animal-free drug development
Curi Bio and Battelle announce strategic partnership to commercialize neuromuscular junction testing technology, positioning for regulatory shift toward human-relevant drug development methods.
Pete McLaughlin exits EVP role after 41 years: What Southern Glazer’s leadership shift says about its regulatory future
Pete McLaughlin exits EVP role at Southern Glazer’s after 41 years—find out how this strategic shift could shape the future of alcohol distribution policy.